chr6-31116203-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001264.5(CDSN):c.1412C>T(p.Pro471Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000663 in 1,613,624 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001264.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDSN | NM_001264.5 | c.1412C>T | p.Pro471Leu | missense_variant | 2/2 | ENST00000376288.3 | NP_001255.4 | |
PSORS1C1 | NM_014068.3 | c.-229+1312G>A | intron_variant | ENST00000259881.10 | NP_054787.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDSN | ENST00000376288.3 | c.1412C>T | p.Pro471Leu | missense_variant | 2/2 | 1 | NM_001264.5 | ENSP00000365465.2 | ||
PSORS1C1 | ENST00000259881.10 | c.-229+1312G>A | intron_variant | 1 | NM_014068.3 | ENSP00000259881.9 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152070Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000564 AC: 14AN: 248370Hom.: 0 AF XY: 0.0000742 AC XY: 10AN XY: 134698
GnomAD4 exome AF: 0.0000677 AC: 99AN: 1461554Hom.: 0 Cov.: 58 AF XY: 0.0000619 AC XY: 45AN XY: 727028
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152070Hom.: 0 Cov.: 31 AF XY: 0.0000539 AC XY: 4AN XY: 74276
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 22, 2023 | The c.1412C>T (p.P471L) alteration is located in exon 2 (coding exon 2) of the CDSN gene. This alteration results from a C to T substitution at nucleotide position 1412, causing the proline (P) at amino acid position 471 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 17, 2023 | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 471 of the CDSN protein (p.Pro471Leu). This variant is present in population databases (rs142570009, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with CDSN-related conditions. ClinVar contains an entry for this variant (Variation ID: 2463530). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CDSN protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at